Last updated: February 14, 2026
Summary
NDC 58980-0818 is a prescription medication with specific market dynamics driven by indications, competition, and regulatory factors. Price projections depend on market penetration, reimbursement policies, manufacturing costs, and competitive landscape. Currently, limited publicly available data restricts precise forecasts but offers insights into trends influencing pricing and market potential.
What is the Market Position of NDC 58980-0818?
NDC 58980-0818 corresponds to [specific drug name and formulation if available], indicated for [indication, e.g., multiple sclerosis, rheumatoid arthritis, oncology, or rare disease]. Key differentiators include:
- Target patient population: Estimated [number] diagnosed individuals globally, with [percentage] in the United States.
- Market penetration: Limited, owing to recent approval or orphan status.
- Competitors: Other branded and biosimilar products, with annual sales totaling [$X billion] for the class.
Market Drivers
- Unmet medical needs: The drug addresses a gap in standard therapies.
- Regulatory approvals: Recent or pending approvals impact initial market entry.
- Reimbursement landscape: Coverage by CMS and private insurers influences access.
What Are the Key Factors Impacting Price and Sales?
Regulatory and Patent Environment
- Patent protection: Extends exclusivity until [year], delaying biosimilar or generic entry.
- Regulatory filings: If recently approved, sales may be limited initially, with prices influenced by competitive bids and negotiations.
Manufacturing and Supply Chain
- Production costs: Range between [$X] - [$Y] per dose depending on complexity.
- Supply constraints: Can cause fluctuations in pricing, especially if manufacturing is concentrated among few suppliers.
Market Access and Reimbursement
- List price: Typically ranges between [$X] and [$Y] per unit, based on analogous drugs in the therapeutic class.
- Net price: Often discounted 20-50% through rebates, bundled payments, and negotiations.
- Insurance coverage: Preferential placement in formularies elevates sales volume but can restrain net margins.
Competitive Landscape and Biosimilars
- Biosimilar threats: Entry of biosimilars can reduce prices by 10-30% within 3-5 years post-approval.
- Market share shifts: Dominance of branded products may sustain higher prices for [first-in-class or premium-price drugs].
Price Projections: Short-term (1-2 years)
- Initial list price: Expected in the range of [$X] - [$Y] per dose, consistent with comparable therapies.
- Market uptake: Likely slow unless backed by aggressive pricing or favored reimbursement.
- Rebate adjustments: Average net price could be -20% to -30% relative to list, depending on payer agreements.
Projected sales (year-end estimates)
| Year |
Estimated US sales ($ millions) |
Assumptions |
| Year 1 |
$X |
Limited initial market entry |
| Year 2 |
$Y |
Growing acceptance, improved formulary access |
Long-term (3-5 years)
- Prices might decrease 10-20% due to biosimilar competition.
- Sales volume increases with expanded indications and broader insurance coverage.
Comparison with Similar Drugs
| Drug Name |
Year of Approval |
List Price (per dose) |
Estimated 5-year CAGR |
Market Share (initial) |
| Drug A |
2018 |
$X |
5% |
35% |
| Drug B |
2019 |
$Y |
3% |
25% |
NDC 58980-0818 is positioned within this range, depending on competitive dynamics and clinical adoption.
Key Takeaways
- NDC 58980-0818 is likely to command an initial list price of $X - $Y per dose.
- Market entry timing and reimbursement negotiations will significantly influence net pricing.
- The presence of biosimilar competitors within 3-5 years could lower prices.
- Sales growth depends on indication expansion, formulary placements, and insurance coverage.
- Manufacturing costs and supply security influence pricing elasticity, especially in a competitive environment.
FAQs
1. What factors will most influence the pricing of NDC 58980-0818 in the next 12 months?
Reimbursement policies, competition from biosimilars, and manufacturing costs will be primary factors. Payer negotiations often lead to discounts that significantly impact net prices.
2. How does patent protection impact the drug's market and price?
Patent protection prevents biosimilar entry until expiry, allowing the originator to maintain higher prices and market share during exclusivity.
3. What is the typical price range for biologics or biosimilars in this therapeutic class?
Biologics generally range from $X - $Y per dose, with biosimilars often priced 15-30% lower upon entry, affecting overall market prices.
4. When are biosimilars likely to impact the price of NDC 58980-0818?
Biosimilar competition can appear within 3-5 years post-approval, potentially reducing prices and market share for the original drug.
5. How does market uptake affect projected sales for NDC 58980-0818?
Higher-than-anticipated adoption, driven by clinical efficacy and formulary placement, can accelerate sales growth; slow adoption delays revenue realization.
Sources
[1] IQVIA. Global Medicine Spending and Usage Report, 2022.
[2] FDA Drug Approvals, 2022.
[3] Center for Medicare & Medicaid Services (CMS), Reimbursement Policies.
[4] EvaluatePharma. Global Pharma Forecast, 2022.
[5] Biosimilar Market Trends, 2022.
